The provider has ordered furosemide 10 mg PO stat. Furosemide is available in 20 mg/tablet. How many tablet(s) should the nurse administer?
(Record the answer to the tenth, or one decimal place. Use a leading zero if it applies. Do not use a trailing zero.)

a) The symptoms described are indicative of hypoglycemia, and addressing the client's emotional state or offering to listen does not address the immediate medical issue.

b) Checking the blood glucose level is crucial to determine if the symptoms are due to hypoglycemia, and providing carbohydrates can help raise the blood sugar level promptly.

c) Assuming a panic attack without assessing the potential hypoglycemic state could delay appropriate intervention.

d) The symptoms described are not consistent with an allergic reaction, so giving diphenhydramine is not the appropriate response.

A) This is not a risk of estrogen/progestin therapy. In fact, estrogen/progestin therapy can help prevent osteoporosis and fractures by increasing bone density and strength.

B) This is a possible risk of estrogen/progestin therapy. Some studies have suggested that taking estrogen/progestin therapy for more than five years may increase the risk of ovarian cancer. However, other studies have not found this association

C) This is a serious risk of estrogen/progestin therapy. Estrogen/progestin therapy can increase the risk of blood clots, which can lead to stroke or heart attack. The risk is higher for women who smoke, have high blood pressure, diabetes, or a history of cardiovascular disease.

D) This is not a risk of estrogen/progestin therapy. In fact, some studies have suggested that estrogen/progestin therapy may reduce the risk of colon cancer by lowering inflammation and promoting regular bowel movements.

E) This is another serious risk of estrogen/progestin therapy. Deep vein thrombosis (DVT) is a condition where a blood clot forms in a deep vein, usually in the leg. It can cause pain, swelling, and redness in the affected area. If the clot breaks off and travels to the lungs, it can cause a life threatening condition called pulmonary embolism (PE). Estrogen/progestin therapy can increase the risk of DVT and PE by making the blood more likely to clot